promoter de-methylation of cyclin d2 by sulforaphane in prostate cancer cells启动子de-methylation萝卜硫素在前列腺癌细胞的细胞周期蛋白d2.pdfVIP

Hsu et al. Clinical Epigenetics 2011, 3:3 /content/3/1/3 RESEARCH Open Access Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells 1,2 1,2 3 2,3 2,3 1,2* Anna Hsu , Carmen P Wong , Zhen Yu , David E Williams , Roderick H Dashwood and Emily Ho Abstract Sulforaphane (SFN), an isothiocyanate derived from cruciferous vegetables, induces potent anti-proliferative effects in prostate cancer cells. One mechanism that may contribute to the anti-proliferative effects of SFN is the modulation of epigenetic marks, such as inhibition of histone deacetylase (HDAC) enzymes. However, the effects of SFN on other common epigenetic marks such as DNA methylation are understudied. Promoter hyper-methylation of cyclin D2, a major regulator of cell cycle, is correlated with prostate cancer progression, and restoration of cyclin D2 expression exerts anti-proliferative effects on LnCap prostate cancer cells. Our study aimed to investigate the effects of SFN on DNA methylation status of cyclin D2 promoter, and how alteration in promoter methylation impacts cyclin D2 gene expression in LnCap cells. We found that SFN significantly decreased the expression of DNA methyltransferases (DNMTs), especially DNMT1 and DNMT3b. Furthermore, SFN significantly decreased methylation in cyclin D2 promoter regions containing c-Myc and multiple Sp1 binding sites. Reduced methlyation of cyclin D2 promoter corresponded to an increase in cyclin D2 transcript levels, suggesting that SFN may de-repress methylation-silenced cyclin D2 by impacting epigenetic pathways. Our results demonstrated the ability of SFN to epigenetically modulate cyclin D2 expression, and provide novel insights into